1. Home
  2. IPSC vs BOC Comparison

IPSC vs BOC Comparison

Compare IPSC & BOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.31

Market Cap

413.0M

Sector

Health Care

ML Signal

HOLD

Logo Boston Omaha Corporation

BOC

Boston Omaha Corporation

HOLD

Current Price

$11.18

Market Cap

377.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
BOC
Founded
2019
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
413.0M
377.5M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
IPSC
BOC
Price
$2.31
$11.18
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$4.25
N/A
AVG Volume (30 Days)
739.4K
170.9K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
91.30
N/A
EPS
N/A
N/A
Revenue
$109,164,000.00
$114,376,348.00
Revenue This Year
N/A
$5.79
Revenue Next Year
N/A
$4.76
P/E Ratio
N/A
N/A
Revenue Growth
1556.76
5.64
52 Week Low
$0.44
$10.90
52 Week High
$2.97
$15.10

Technical Indicators

Market Signals
Indicator
IPSC
BOC
Relative Strength Index (RSI) 50.25 37.20
Support Level $2.15 $11.17
Resistance Level $2.67 $12.82
Average True Range (ATR) 0.12 0.43
MACD 0.00 -0.06
Stochastic Oscillator 62.00 39.72

Price Performance

Historical Comparison
IPSC
BOC

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

About BOC Boston Omaha Corporation

Boston Omaha Corp is a diversified holding company engaged in outdoor billboard advertising, broadband services, surety insurance, and related brokerage activities, and asset management. The company generates revenue mainly from leasing advertising space on billboards, providing broadband internet services, and earning premiums and commissions from its insurance operations. In addition, it holds minority equity investments in various businesses, including real estate-related and other industries.

Share on Social Networks: